Clinical Trial – media

Discovery of Rosehip Neurons in Humans

Have you ever wondered why scientists conduct experiments on rodents during clinical trials? Scientists claim that rodents resemble humans in terms of genetics. Scientists from the Allen Institute for Brain Science were focussing their research work to find out which specific brain cells are present in humans but not in rodents.
- Source: FierceBiotech
- 804
- August 29, 2018
Clinical Trial neurological
Next Generation Drug Could Treat Inherited Form of ALS in Animal Models

New research funded by the NIH found that a second-generation drug, when injected in rodents, deferred signs of amyotrophic lateral sclerosis (ALS).
- Source: ScienceDaily
- 544
- August 2, 2018
ALS Clinical Trial Researches
Mersana’s Lead Cancer ADC Held Up by FDA for Patient’s Death

The FDA held up Mersana’s top antibody-drug conjugate (ADC), XMT-1522 over safety issues following a patient’s death in phase 1 trial, causing a descent in the company’s shares.
- Source: FierceBiotech
- 198
- July 25, 2018
cancer Clinical Trial FDA
Luspatercept Passes Phase 3 Clinical Trial for Rare Blood Disease

Acceleron Pharma and its partner Celgene have revealed that luspatercept hit its primary and secondary endpoints in phase 3 clinical trial of patients affected with chronic anemia associated with a rare blood disease.
- Source: FierceBiotech
- 659
- July 3, 2018
blood cancer Clinical Trial
Probiotics for Liver Health

Probiotics are defined as beneficial bacteria that are consumed to boost the populations of more beneficial microbes. The importance of probiotics in health improvement seems to be growing worldwide with more awareness of the benefits. For this reason, numerous research works are currently being conducted in the field of probiotics.
- Source: MedicalXpress; Healthline
- 760
- June 15, 2018
Clinical Trial health tips liver diseases Probiotics
Strong Growth Potential in Global Clinical Trial Data Management and eClinical Solutions Market to Cross $4 Billion by 2020

Unified cloud-based eClinical platforms, with built-in scalability and modularity, will drive growth opportunities across the globe
- Source: PR Newswire
- 684
- April 12, 2018
Clinical Trial Market Views mHealth
Leading CROs, Veeva team up for open tech on trials

Six big contract research companies, alongside Veeva Systems, are for the first time coming together to develop open technology standards aimed at “transforming clinical trial ops” to speed up development.
- Source: fiercebiotech
- 581
- March 30, 2018
Clinical Trial CRO
Denali Therapeutics Announces First-In-Human Dosing Of Its RIPK1 Inhibitor Clinical Program And The Appointment Of Peter Klein To Board Of Directors;

Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today announced that it has commenced dosing of its small molecule inhibitor of RIPK1 in a Phase 1 clinical trial in healthy volunteers and achieved proof of concept of its large molecule blood-brain barrier delivery platform technology in nonhuman primates.
- Source: Nasdaq
- 558
- March 21, 2018
Clinical Trial neurodegenerative disease RIPK1
ViiV kicks off PhIII trial of two-drug HIV regimen

ViiV Healthcare, an HIV specialist firm majority owned by GlaxoSmithKline, has announced the launch of a late-stage study investigating the effectiveness of a two-drug regimen programme in patients with HIV.
- Source: pharmatimes
- 568
- February 12, 2018
Clinical Trial HIV Phase TANGO
Genentech’s Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial

Genentech’s PD-L1 inhibitor Tecentriq continues to show off its versatility. Monday, the Roche subsidiary announced a combination of Tecentriq and Avastin (bevacizumab) was significantly beneficial to patients with advanced or metastatic renal cell carcinoma (mRCC) who have not received prior systemic active or experimental therapy.
- Source: Biospace
- 657
- February 11, 2018
Clinical Trial inhibitor mRCC Tecentriq

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.